CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | AyurMaya Capital Management Company, LP Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −5,336,489 | 0 | ||
| 2024-07-01 | AyurMaya Capital Management Company, LP Director | Conversion · Series C Redeemable Convertible Preferred Stock | −12,745,916 | 0 | ||
| 2024-07-01 | Yao Zhengbin Director | Returned to the company | −23,529 | 0 | ||
| 2024-07-01 | Yao Zhengbin Director | Grant or award | +23,529 | 23,529 | ||
| 2024-07-01 | Yao Zhengbin Director | Returned to the company · Stock Option (Right to Buy) | −31,016 | 0 | ||
| 2024-07-01 | Yao Zhengbin Director | Grant or award · Stock Option (Right to Buy) | +31,016 | 31,016 | ||
| 2024-07-01 | Yao Zhengbin Director | Returned to the company · Stock Option (Right to Buy) | −4,278 | 0 | ||
| 2024-07-01 | Yao Zhengbin Director | Grant or award · Stock Option (Right to Buy) | +4,278 | 4,278 | ||
| 2024-07-01 | Srivastava Sapna Director | Returned to the company · Stock Option (Right to Buy) | −28,877 | 0 | ||
| 2024-07-01 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +28,877 | 28,877 | ||
| 2024-07-01 | Srivastava Sapna Director | Returned to the company · Stock Option (Right to Buy) | −29,946 | 0 | ||
| 2024-07-01 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +29,946 | 29,946 | ||
| 2024-07-01 | Machado Patrick Director | Returned to the company · Stock Option (Right to Buy) | −38,000 | 0 | ||
| 2024-07-01 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2024-07-01 | AKKARAJU SRINIVAS Director | Conversion | +1,703,998 | 1,703,998 | ||
| 2024-07-01 | AKKARAJU SRINIVAS Director | Returned to the company | −1,703,998 | 0 | ||
| 2024-07-01 | AKKARAJU SRINIVAS Director | Grant or award | +1,703,998 | 1,703,998 | ||
| 2024-07-01 | AKKARAJU SRINIVAS Director | Conversion · Series C Preferred Stock | −1,703,998 | 0 | ||
| 2024-07-01 | Richardson Derrick SVP, People and Culture | Returned to the company · Stock Option (Right to Buy) | −3,208 | 0 | ||
| 2024-07-01 | Richardson Derrick SVP, People and Culture | Grant or award · Stock Option (Right to Buy) | +3,208 | 3,208 |
Page 13 of 21 · 405 trades